Trial
NCT02472977
Safety and Efficacy Study of Ulocuplumab and Nivolumab in Subjects With Solid Tumors
Phase ITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Bristol-Myers Squibb
Collaborators
—
Condition
Solid Tumor
Intervention
Ulocuplumab
Why stopped
Trial terminated because of lack of efficacy in the short term acute phase
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-11-01